Moneycontrol
YOU ARE HERE > Moneycontrol > Mutual Funds > Evaluate > Performance Tracker : Sector - Pharma & Healthcare
Performance Tracker

Sector - Pharma & Healthcare

Funds with an investment objective to invest in pharmaceutical, healthcare and related sectors.
Sector - Pharma & Healthcare - Returns (in %) - as on Jul 24, 2017
Compare With Indices
  • Sensex
  • Nifty
  • BANK Nifty
  • BANKEX
  • BSE Auto
  • BSE CD INDEX
  • BSE FMCG INDEX
  • BSE HEALTHCARE
  • BSE IPO
  • BSE IT INDEX
  • BSE Metal
  • BSE Oil & Gas
  • BSE POWER INDEX
  • BSE PSU INDEX
  • BSE REALTY
  • BSE TECk INDEX
  • BSE-100
  • BSE-200
  • BSE-500
  • BSE-MIDCAP
  • BSE-SMALLCAP
  • CAPITAL GOODS
  • CNX 100
  • CNX IT
  • CNX Midcap
  • CNX NIFTY JR
  • Nifty Midcap 50
  • S&P CNX 500
  • S&P CNX Defty

Mutual Fund Scheme

Crisil Rank AUM
(Rs. cr.)
Mar 17
1mth 3mth 6mth 1yr 2yr 3yr 5yr  
* Returns over 1 year are Annualised
Sponsored Advt.
Reliance Pharma Fund (G) Not Ranked
1,321.80 4.9 0.6 0.8 -5.5 -1.7 10.4 17.3
Reliance Pharma Fund - Direct (G) Not Ranked
149.74 5.0 0.8 1.3 -4.7 -0.8 11.4 --
Reliance Pharma Fund (G) Not Ranked
1,321.80 4.9 0.6 0.8 -5.5 -1.7 10.4 17.3
UTI Pharma & Health - Direct (G) Not Ranked
21.81 4.7 -0.7 0.8 -7.1 -3.7 8.7 --
Tata India Pharma & HealthCare -Dir (G) Not Ranked
9.95 4.0 -3.5 3.9 -7.2 -- -- --
UTI Pharma & Health (G) Not Ranked
297.82 4.7 -1.0 0.4 -7.9 -4.6 7.7 15.5
SBI Pharma Fund - Direct (G) Not Ranked
191.85 4.7 -2.5 -1.2 -8.6 -3.4 12.4 --
Tata India Pharma & HealthCare - RP (G) Not Ranked
71.60 3.9 -3.8 3.1 -8.7 -- -- --
SBI Pharma Fund (G) Not Ranked
844.57 4.6 -2.7 -1.8 -9.7 -4.6 11.0 20.0
CATEGORY AVERAGE 4.4 -2.0 1.5 -7.3 -2.6 7.6 13.3

Note : Returns have been calculated based on NAV's as on Jul 24, 2017 & Index values as on Jul 24, 2017

As per AMFI guidelines, effective from quarter ending December 31, 2010, fund houses have stopped publishing the Assets Under Management (AUM) on a monthly basis. This data is published every quarter.

Quick Links (Mouseover on for more information)
Sections
Follow us on
Available On